Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005
Management of chronic obstructive pulmonary disease (COPD) exacerbations: results of a French cohort study Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008
Should chronic obstructive pulmonary disease patients must be vaccinated? Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013
Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006
Vaccination efficacy in workers with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 107s Year: 2006
Genomic variability of haemophilus in patients with COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006
Clinical effect of different pneumococcal vaccination schedules in patients with chronic obstructive pulmonary disease (COPD): long-term follow-up results Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
Exacerbations and associated health-care cost in patients with chronic obstructive pulmonary disease (COPD) in general practice. Results from the COOPT trial Source: Eur Respir J 2002; 20: Suppl. 38, 398s Year: 2002
Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006
Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015
Rate of flu vaccination in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 144s Year: 2004
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013
Effectiveness of a community based pulmonary rehabilitation (PR) programme for patients with chronic obstructive pulmonary disease (COPD): A retrospective review Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017
Predictors of exacerbation frequency in chronic obstructive pulmonary disease Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
An epidemiologic study for chronic obstructive pulmonary disease (COPD) with pre-screening by a questionnaire Source: Eur Respir J 2005; 26: Suppl. 49, 594s Year: 2005
Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019
Risk of pneumonia in chronic obstructive pulmonary disease patients treated with inhaled corticosteroids. Results from the OUTPUL study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016
Hospitalization, mortality and vaccine effectiveness in a group of chronic obstructive pulmonary disease (COPD) patients during influenza season 1999 - 2000 Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001
Hospitalization for influenza among patients with chronic obstructive pulmonary disease Source: International Congress 2019 – Airway infection in COPD Year: 2019
Venous thromboembolic (VTE) disease in people with chronic obstructive pulmonary disease (COPD): A matched case-control study Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015